Medtronic: An Undervalued Stock With Durable Competitive Advantages
Medtronic(MDT) Seeking Alpha·2024-09-16 21:00
CottonCandyClouds/iStock via Getty Images Medtronic PLC (NYSE:MDT) is a global developer and manufacturer of medical devices for chronic diseases. Founded in 1949, Medtronic is now a $111 billion (by market cap) healthcare behemoth that employs 95,000 people. The company reports results across four segments: Cardiovascular, 37% of FY 2023 revenue; Neuroscience, 29%; Medical Surgical, 27%; and Diabetes, 7%. Medtronic's product portfolio is comprised of a variety of life-saving and life-improving medical devi ...